Search Results | Showing 951 - 960 of 2997 results for "February 11" |
| | | ASIC has permanently banned an ACT financial adviser over dodgy SMSF advice, and banned another from NSW for three years for failing to consider clients' best interests. Jane Myers, an authorised representative of Spectrum Wealth between 2013 and 2017 ... |
| | | | Mission accomplished! This would have been the Reserve Bank of Australia's (RBA) self-congratulatory exclamation after the Australian Bureau of Statistics (ABS) reported that annual headline CPI inflation accelerated to 2.2% in the March quarter ... |
| | | | OneVue is on track on complete the sale of dealer group Madison next month, the company said in quarterly update released this morning. OneVue took control of Madison Group in early February from Sargon Capital, as the ASX-listed companies tries to ... |
| | | | Investors redeemed over $3.8 billion from local managed funds in April, in the largest monthly net outflows on record, according to Calastone. So far, November 2018 has been the only month with material net outflows in Australia as investors responded ... |
| | | | The spreads on many exchange-traded products were wider than usual amid the COVID-19 market crash, with price discovery becoming increasingly more difficult. That's according to ETF Securities co-head of sales Kanish Chugh, who pointed to global equity ... |
| | | | ... March. These contrast with the rebound in the Caixin China composite PMI to a reading of 46.7 in March from 27.5 in February (no April update yet) - with the services PMI jumping to 43.0 in March from 26.5 in the previous month and the manufacturing ... |
| | | | UBS estimates that it may take over three years to return to 2019 dividend payouts due to COVID-19 related cuts and suspensions. UBS equity strategist Pieter Stoltz said, based on UBS forecasts, market earnings per share (EPS) will not return to financial ... |
| | | | The investment world's underdog has seen a surge in interest since it hit rock bottom in March, outperforming the US market indices by a mile. Bitcoin, which started the year rising from US$7500 to US$10,5O0, fell just as badly as every other asset ... |
| | | | News that a highly anticipated antiviral drug hoped to treat COVID-19 had flopped in human trials saw markets fall overnight. Originally reported by the Financial Times, the publisher said Gilead Sciences antiviral drug remdesivir did not reduce the ... |
| | | | New customer satisfaction data shows members' opinions of industry superannuation funds are starting to turn, after weeks of scrutiny over their performance during the COVID-19 crisis. According to Roy Morgan's latest superannuation customer satisfaction ... |
|